Читать книгу Nanobiotechnology in Diagnosis, Drug Delivery and Treatment - Группа авторов - Страница 3

1 Chapter 4Table 4.1 Examples of commercially available Gd³⁺ chelate T₁‐Weighted MRI con...Table 4.2 Examples of commercially available IONP‐based T₂‐weighted MRI contr...Table 4.3 Typical combined applications of Au NRs.

2 Chapter 7Table 7.1 Superparamagnetic iron oxide nanoparticle‐based AMF‐induced in vitr...Table 7.2 Superparamagnetic iron oxide nanoparticle‐based AMF‐induced in vivo...

3 Chapter 8Table 8.1 Various plant virus nanoparticles and their potential applications ...

4 Chapter 9Table 9.1 Classification of iron oxide particles according to their size.

5 Chapter 10Table 10.1 Factors affecting antimicrobial activity of chitosan.

6 Chapter 11Table 11.1 Various biomaterials used for synthesis of SNPs.

7 Chapter 12Table 12.1 Details about antifungal efficacy of different nanoparticles again...

8 Chapter 13Table 13.1 Examples of commercially available antifungal nanoformulated drugs...

9 Chapter 14Table 14.1 Dose‐dependent RBC lysis assay of ChBio‐AgNPs.

10 Chapter 15Table 15.1 Clinical and epidemiological characteristics of the mainLeishmaniaTable 15.2 Chemical structure and selected properties of existing antileishma...Table 15.3 A survey of reports on polymeric nanoparticles made from biodegrad...Table 15.4 Micellar drug delivery devices made from copolymers as appearing i...Table 15.5 Nanodrug delivery devices intended for treatment of leishmanial in...Table 15.6 Some selected reports on using bioconjugate drug delivery devices ...Table 15.7 Some selected reports on using inclusion compounds for treatment o...Table 15.8 Drug delivery devices developed for antileishmanial agents based o...Table 15.9 Selected liposomal drug delivery systems appearing in the literatu...Table 15.10 Other vesicular nanoparticles including niosomes, emulsomes, and ...Table 15.11 Nanodrug delivery vehicles based on solid lipid nanoparticles and...Table 15.12 Micro‐ and nanoemulsion products reported for treatment of leishm...Table 15.13 Nanodrug and nanosuspension products reported for treatment of le...Table 15.14 Inorganic nanoparticles used as antileishmanial agents per se or ...

11 Chapter 16Table 16.1 Vaccine‐theranostics that potentiate active antigens into cells to...Table 16.2 Evaluation of nanotherapy by imaging in cardiovascular illness as ...